164 related articles for article (PubMed ID: 8013978)
1. Clinical relevance of fractionation characteristics in cascade filtration.
Busnach G; Mandelli E; Brando B; Brunati C
Int J Artif Organs; 1993 Dec; 16 Suppl 5():155-9. PubMed ID: 8013978
[TBL] [Abstract][Full Text] [Related]
2. Different cascade filtration operating modalities in clinical use.
Busnach G; Dal Col A; Brando B; Cappelleri A; Perrino ML; Brunati C; Minetti L
Int J Artif Organs; 1988 Nov; 11(6):493-6. PubMed ID: 3144514
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and clinical evaluation of a new cellulose diacetate secondary filter for cascade filtration.
Valbonesi M; Tarantino M; Montani F; Florio G; Romorini A
Int J Artif Organs; 1985 Mar; 8(2):105-8. PubMed ID: 3921467
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
Siami GA; Siami FS
Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
[TBL] [Abstract][Full Text] [Related]
5. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
Lai KN; Cheng SC; Vallance-Owen J
Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
Waldenström JG; Raiend U
Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
[TBL] [Abstract][Full Text] [Related]
7. The use of emergency apheresis in the management of plasma cell disorders.
Kalayoglu-Besisik S
Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and clinical application. d. Hyperviscosity syndrome].
Ito K
Nihon Rinsho; 1984 Aug; 42(8):1870-4. PubMed ID: 6513056
[No Abstract] [Full Text] [Related]
9. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
[TBL] [Abstract][Full Text] [Related]
10. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
[TBL] [Abstract][Full Text] [Related]
11. Plasma viscosity changes after sham plasmapheresis.
Jakoet A; Martell RW; Jacobs P
Lancet; 1987 Oct; 2(8566):1031-2. PubMed ID: 2889944
[No Abstract] [Full Text] [Related]
12. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
Kaplan AA
Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis and hyperviscosity syndrome].
Corral Alonso M; Barbolla ML
Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
[No Abstract] [Full Text] [Related]
14. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
15. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
[No Abstract] [Full Text] [Related]
16. Apheresis in hematologic and oncologic disease.
Cohen RJ
Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
[TBL] [Abstract][Full Text] [Related]
17. Plasmapheresis in the dysproteinemias.
Drew MJ
Ther Apher; 2002 Feb; 6(1):45-52. PubMed ID: 11886576
[TBL] [Abstract][Full Text] [Related]
18. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
Mokeeva RA; Zhuravlev VS
Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
[No Abstract] [Full Text] [Related]
19. Effect of membrane trapping in plasma fractionator on separative characteristics.
Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of discontinuous flow centrifugation compared with cascade filtration in Waldenstrom's macroglobulinemia: a pilot study.
Valbonesi M; Montani F; Guzzini F; Angelini G; Florio G
Int J Artif Organs; 1985 May; 8(3):165-8. PubMed ID: 3928502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
